Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nimodipine Systemic Exposure and Outcomes Following Aneurysmal Subarachnoid Hemorrhage: A Prospective Multi-centre Observational Study (ASH-II Study)

NCT07065903 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT07065903
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07065903 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nimodipine Systemic Exposure and Outcomes Following Aneurysmal Subarachnoid Hemorrhage: A Prospective Multi-centre Observational Study (ASH-II Study)
Lead sponsor
University of Alberta
Phase
Observational
Overall status
Recruiting
Start date
May 13, 2024
Completion date
September 30, 2029
Enrollment
500 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

subarachnoid aneurysm hemorrhage, subarachnoid hemorrhage, aneurysmal